留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

以颈椎压迫症状为首发表现的肝细胞癌伴椎管转移1例报告

魏伏 王健 贺彩妮 赵蕴玉 李锋涛 纪泛扑

魏伏, 王健, 贺彩妮, 等. 以颈椎压迫症状为首发表现的肝细胞癌伴椎管转移1例报告[J]. 临床肝胆病杂志, 2021, 37(1): 156-157. DOI: 10.3969/j.issn.1001-5256.2021.01.031
引用本文: 魏伏, 王健, 贺彩妮, 等. 以颈椎压迫症状为首发表现的肝细胞癌伴椎管转移1例报告[J]. 临床肝胆病杂志, 2021, 37(1): 156-157. DOI: 10.3969/j.issn.1001-5256.2021.01.031
WEI F, WANG J, HE CN, et al. Hepatocellular carcinoma with intraspinal metastasis initially manifesting as cervical cord compression: A case report [J]. J Clin Hepatol, 2021, 37(1): 156-157. DOI: 10.3969/j.issn.1001-5256.2021.01.031
Citation: WEI F, WANG J, HE CN, et al. Hepatocellular carcinoma with intraspinal metastasis initially manifesting as cervical cord compression: A case report [J]. J Clin Hepatol, 2021, 37(1): 156-157. DOI: 10.3969/j.issn.1001-5256.2021.01.031

以颈椎压迫症状为首发表现的肝细胞癌伴椎管转移1例报告

DOI: 10.3969/j.issn.1001-5256.2021.01.031
详细信息
    作者简介:

    魏伏(1989—),女,主要从事重症感染方面的研究

    通讯作者:

    纪泛扑,jifanpu1979@163.com

  • 作者贡献声明:魏伏负责实施研究,收集、分析、解释数据, 起草文章; 王健负责实施研究,分析、解释数据; 贺彩妮负责实施研究,分析、解释数据; 赵蕴玉负责实施研究,采集数据; 李锋涛负责实施研究,外科手术,收集、分析、解释数据,指导文章撰写; 纪泛扑负责酝酿、设计、实施研究,采集数据,分析、解释数据,修改文章。
  • 中图分类号: R735.7

Hepatocellular carcinoma with intraspinal metastasis initially manifesting as cervical cord compression: A case report

  • 图  1  影像学检查结果

    注:a,肝脏CT示肝内巨块型异常密度影,直径约135.66 mm;b,颈椎MRI示C5、C6椎体形态及信号异常,并向椎管突出。

    图  2  颈椎术后病理结果(HE染色)

    注:a, ×40;b, ×100。

  • [1] WANG FS, FAN JG, ZHANG Z, et al. The global burden of liver disease: The major ipact of China[J]. Hepatology, 2014, 60(6): 2099-2108. DOI: 10.1002/hep.27406
    [2] CHEN WQ, ZHENG RS, BAADE PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338
    [3] WU W, HE X, ANDAYANI D, et al. Pattern of distant extrahepatic metastases in primary liver cancer: A SEER based study[J]. J Cancer, 2017, 8(12): 2312-2318. DOI: 10.7150/jca.19056
    [4] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of hepatitis C (2019 version)[J]. J Clin Hepatol, 2019, 35(12): 2670-2686. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.12.008

    中华医学会肝病学分会, 中华医学会感染病分会. 丙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2670-2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008
    [5] Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.12.007

    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007
    [6] TAMAKI K, SHIMIZU I, URATA M, et al. A patient with spinal metastasis from hepatocellular carcinoma discovered from neurological findings[J]. World J Gastroenterol, 2007, 13(19): 2758-2760. DOI: 10.3748/wjg.v13.i19.2758
    [7] OKAMOTO H, SHINKAI T, MATSUNO Y, et al. Intradural parenchymal involvement in the spinal subarachnoid space associated with primary lung cancer[J]. Cancer, 1993, 72: 2583-2588. DOI: 10.1002/1097-0142(19931101)72:9<2583::AID-CNCR2820720912>3.0.CO;2-K
    [8] BHATIA R, RAVULAPATI S, BEFELER A, et al. Hepatocellular carcinoma with bone metastases: Incidence, prognostic significance, and management—Single-Center Experience[J]. J Gastrointest Cancer, 2017, 48(4): 321-325. DOI: 10.1007/s12029-017-9998-6
    [9] CARRAT F, FONTAINE H, DORIVAL C, et al. ANRS CO22 Hepather cohort. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: A prospective cohort study[J]. Lancet, 2019, 393: 1453-1464. DOI: 10.1016/S0140-6736(18)32111-1
    [10] JI FP, ZHANG S, DENG H, et al. Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis[J]. J Hepatol, 2013, 58(6): 1262-1264. DOI: 10.1016/j.jhep.2013.01.041
    [11] JI FP, ZHOU R, WANG WJ, et al. High post-treatment α-fetoprotein levels and aspartate aminotransferase-to-platelet ratio index predict hepatocellular carcinoma in hepatitis C virus decompensated cirrhotic patients with sustained virological response after antiviral therapy[J]. J Interferon Cytokine Res, 2017, 37(8): 362-368. DOI: 10.1089/jir.2017.0040
  • 加载中
图(2)
计量
  • 文章访问数:  103
  • HTML全文浏览量:  20
  • PDF下载量:  12
  • 被引次数: 0
出版历程
  • 收稿日期:  2020-06-07
  • 修回日期:  2020-06-28
  • 刊出日期:  2021-01-18
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回